ZN-c3 is Wee1 inhibitor with anticancer activity and is being investigated in phase 2 clinical trials. It inhibits Wee1 with IC50 of 3.8 nM).
纯度：≥98%
CAS：2376146-48-2
m.cnreagent.com
